Skip to main content
. 2022 Feb 26;15(8):1475–1482. doi: 10.1093/ckj/sfac062

Table 2.

Clinical approach to renal adverse effects of ALK inhibitors

Adverse event Mechanism Management
Renal cyst Unknown Self-limiting, not to be confused with tumor progression
Peripheral edema Inhibition of c-MET Diuretics only to be used if severe edema. Be mindful of electrolyte imbalances
Elevated serum creatinine Pseudo AKI, ATN Check Cystatin Cbased glomerular filtration rate to rule out pseudo-AKI. If ATN, drug needs to be withheld
Proteinuria Likely podocytopathies Consider holding or decreasing dose